 |
 Video: What is a Stock Split?
|
|
|
| AgeX Therapeutics is a biotechnology company focused on the development and commercialization of therapeutics targeting human aging and degenerative diseases. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows it to utilize telomerase-expressing regenerative pluripotent stem cell (PSC) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s product candidates in the discovery stage include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology. According to our AGE split history records, AgeX Therapeutics has had 5 splits. | |
|
AgeX Therapeutics (AGE) has 5 splits in our AGE split history database. The first split for AGE took place on May 12, 1986. This was a 3 for 2
split, meaning for each 2
shares of AGE owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split. AGE's second split took place on July 01, 1991. This was a 3 for 2
split, meaning for each 2
shares of AGE owned pre-split, the shareholder now owned 3 shares. For example, a 1500 share position pre-split, became a 2250 share position following the split. AGE's third split took place on April 01, 1992. This was a 5 for 4
split, meaning for each 4
shares of AGE owned pre-split, the shareholder now owned 5 shares. For example, a 2250 share position pre-split, became a 2812.5 share position following the split. AGE's 4th split took place on January 04, 1994. This was a 5 for 4
split, meaning for each 4
shares of AGE owned pre-split, the shareholder now owned 5 shares. For example, a 2812.5 share position pre-split, became a 3515.625 share position following the split. AGE's 5th split took place on October 01, 1997. This was a 3 for 2
split, meaning for each 2
shares of AGE owned pre-split, the shareholder now owned 3 shares. For example, a 3515.625 share position pre-split, became a 5273.4375 share position following the split.
When a company such as AgeX Therapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the AGE split history from start to finish, an original position size of 1000 shares would have turned into 5273.4375 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgeX Therapeutics shares, starting with a $10,000 purchase of AGE, presented on a split-history-adjusted basis factoring in the complete AGE split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/30/2018 |
|
| End date: |
06/07/2023 |
|
| Start price/share: |
$5.40 |
|
| End price/share: |
$0.59 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-89.07% |
|
| Average Annual Total Return: |
-38.74% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,092.71 |
|
| Years: |
4.52 |
|
|
|
| Date |
Ratio |
| 05/12/1986 | 3 for 2
| | 07/01/1991 | 3 for 2
| | 04/01/1992 | 5 for 4
| | 01/04/1994 | 5 for 4
| | 10/01/1997 | 3 for 2
|
|
|
Free AGE Email Alerts:
